Literature DB >> 10677482

A structural basis for integrin activation by the cytoplasmic tail of the alpha IIb-subunit.

O Vinogradova1, T Haas, E F Plow, J Qin.   

Abstract

A key step in the activation of heterodimeric integrin adhesion receptors is the transmission of an agonist-induced cellular signal from the short alpha- and/or beta-cytoplasmic tails to the extracellular domains of the receptor. The structural details of how the cytoplasmic tails mediate such an inside-out signaling process remain unclear. We report herein the NMR structures of a membrane-anchored cytoplasmic tail of the alpha(IIb)-subunit and of a mutant alpha(IIb)-cytoplasmic tail that renders platelet integrin alpha(IIb)beta(3) constitutively active. The structure of the wild-type alpha(IIb)-cytoplasmic tail reveals a "closed" conformation where the highly conserved N-terminal membrane-proximal region forms an alpha-helix followed by a turn, and the acidic C-terminal loop interacts with the N-terminal helix. The structure of the active mutant is significantly different, having an "open" conformation where the interactions between the N-terminal helix and C-terminal region are abolished. Consistent with these structural differences, the two peptides differ in function: the wild-type peptide suppressed alpha(IIb)beta(3) activation, whereas the mutant peptide did not. These results provide an atomic explanation for extensive biochemical/mutational data and support a conformation-based "on/off switch" model for integrin activation.

Mesh:

Substances:

Year:  2000        PMID: 10677482      PMCID: PMC26454          DOI: 10.1073/pnas.040548197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Design and chemical synthesis of a neoprotein structural model for the cytoplasmic domain of a multisubunit cell-surface receptor: integrin alpha IIb beta 3 (platelet GPIIb-IIIa).

Authors:  T W Muir; M J Williams; M H Ginsberg; S B Kent
Journal:  Biochemistry       Date:  1994-06-21       Impact factor: 3.162

2.  A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies.

Authors:  J A Peterson; G P Visentin; P J Newman; R H Aster
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

3.  Breaking the integrin hinge. A defined structural constraint regulates integrin signaling.

Authors:  P E Hughes; F Diaz-Gonzalez; L Leong; C Wu; J A McDonald; S J Shattil; M H Ginsberg
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

Review 4.  Integrins: emerging paradigms of signal transduction.

Authors:  M A Schwartz; M D Schaller; M H Ginsberg
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

5.  Interaction of plasma membrane fibronectin receptor with talin--a transmembrane linkage.

Authors:  A Horwitz; K Duggan; C Buck; M C Beckerle; K Burridge
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

6.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

7.  Membrane interaction of small N-myristoylated peptides: implications for membrane anchoring and protein-protein association.

Authors:  M B Sankaram
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

8.  On choosing a detergent for solution NMR studies of membrane proteins.

Authors:  O Vinogradova; F Sönnichsen; C R Sanders
Journal:  J Biomol NMR       Date:  1998-05       Impact factor: 2.835

9.  Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb.

Authors:  T E O'Toole; D Mandelman; J Forsyth; S J Shattil; E F Plow; M H Ginsberg
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

10.  Differential structural requirements for fibrinogen binding to platelets and to endothelial cells.

Authors:  L Tranqui; A Andrieux; G Hudry-Clergeon; J J Ryckewaert; S Soyez; A Chapel; M H Ginsberg; E F Plow; G Marguerie
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

View more
  39 in total

1.  Solution structures of the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-subunits.

Authors:  Aalim M Weljie; Peter M Hwang; Hans J Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

2.  Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains.

Authors:  R Li; C R Babu; J D Lear; A J Wand; J S Bennett; W F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  Binding strength and activation state of single fibrinogen-integrin pairs on living cells.

Authors:  Rustem I Litvinov; Henry Shuman; Joel S Bennett; John W Weisel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Avidity modulation activates adhesion under flow and requires cooperativity among adhesion receptors.

Authors:  Na Ni; Christopher G Kevil; Daniel C Bullard; Dennis F Kucik
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

5.  Transmembrane signal transduction of the alpha(IIb)beta(3) integrin.

Authors:  Kay E Gottschalk; Paul D Adams; Axel T Brunger; Horst Kessler
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

6.  Suppression of integrin activation by the membrane-distal sequence of the integrin alphaIIb cytoplasmic tail.

Authors:  Jun Yamanouchi; Takaaki Hato; Tatsushiro Tamura; Shigeru Fujita
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

7.  Membrane-mediated structural transitions at the cytoplasmic face during integrin activation.

Authors:  Olga Vinogradova; Julia Vaynberg; Xiangming Kong; Thomas A Haas; Edward F Plow; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

Review 8.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

9.  Tyrosine phosphorylation as a conformational switch: a case study of integrin β3 cytoplasmic tail.

Authors:  Lalit Deshmukh; Nahum Meller; Nathan Alder; Tatiana Byzova; Olga Vinogradova
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 10.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.